arrow
K

Kirsten I. Taylor

f hoffmann-la roche ltd
H指数:41
被引数:4,861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From feasibility to neuroanatomic validity of remote cognitive smartphone assessments in early Alzheimer’s disease

从可行性到神经解剖学效度:远程认知智能手机评估在早期阿尔茨海默病中的应用

2026-09-050
OA
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

帕金森病患者接受prasinezumab治疗后运动体征进展的探索性数字结局指标

2025-06-160
OAAI
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
2025-03-010
OAAI
Trial of Prasinezumab in Early-Stage Parkinson's Disease

Prasinezumab在早期帕金森病中的试验

2022-08-04170
OA
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
2021-05-0416
OA
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
2020-11-2439
OAAI
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
2020-01-0186
OAAI
Evaluation of Smartphone-Based Testing to Generate Exploratory Outcome Measures in a Phase 1 Parkinson's Disease Clinical Trial

在1期帕金森病临床试验中评估基于智能手机的测试以产生探索性结果指标

2018-04-27175
OAAI